Minocycline-Induced Blue-Green Discoloration of Bone: A Case Report

Journal of Bone and Joint Surgery

Volumn 86, Issue 1, 2004, Pages 146-148

  McCleskey, Patrick E ^a   Littleton, Kamala H ^b  

^a DAVID GRANT MEDICAL CENTER   (United States)

^b MERCY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; FELODIPINE; MINOCYCLINE; OXYBUTYNIN; RABEPRAZOLE; ROFECOXIB;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE DISCOLORATION; BONE DISEASE; CASE REPORT; CLINICAL FEATURE; CORTICAL BONE; HUMAN; HYPERPIGMENTATION; KNEE ARTHRITIS; KNEE OSTEOARTHRITIS; KNEE PAIN; KNEE RADIOGRAPHY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; ROSACEA; TOTAL KNEE REPLACEMENT; TREATMENT FAILURE;

EID: 0348223817     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200401000-00023     Document Type: Article

References (14)

1. Fenske NA, Milins JL. Cutaneous pigmentation due to minocycline hydrochloride. J Am Acad Dermatol. 1980;3:308-10.
2. Basler RS. Minocycline-related hyperpigmentation. Arch Dermatol. 1985;121:606-8.
3. Eisen D, Hakim MD. Minocycline-induced pigmentation. Incidence, prevention, and management. Drug Saf. 1998;18:431-40.
4. Ozog DM, Gogstetter DS, Scott G, Gaspari AA. Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid. Arch Dermatol. 2000;136:1133-8.
5. Westbury LW, Najera A. Minocycline-induced intraoral pharmacogenic pigmentation: case reports and review of the literature. J Periodontol. 1997;68:84-91.
6. Wolfe ID, Reichmister J. Minocycline hyperpigmentation: skin, tooth, nail, and bone involvement. Cutis. 1984;33:457-8.
7. Rumbak MJ, Pitcock JA, Palmieri GM, Robertson JT. Black bones following long-term minocycline treatment. Arch Pathol Lab Med. 1991;115:939-41.
8. Ridgway HA, Sonnex TS, Kennedy CT, Millard PR, Henderson WJ, Gold SC. Hyperpigmentation associated with oral minocycline. Br J Dermatol. 1982;107:95-102.
9. Klapisz-Wollkow M, Saffar JL. Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat. J Cell Physiol. 1996;167:359-68.
10. Oklund SA, Prolo DJ, Gutierrez RV. The significance of yellow bone. Evidence for tetracycline in adult human bone. JAMA. 1981;246:761-3.
11. Dahners LE, Bos GD. Fluorescent tetracycline labeling as an aid to debridement of necrotic bone in the treatment of chronic osteomyelitis. J Orthop Trauma. 2002;16;345-6.
12. Cale AE, Freedman PD, Lumerman H. Pigmentation of the jawbones and teeth secondary to minocycline hydrochloride therapy. J Periodontol. 1988;59:112-4.
13. Williams S, Wakisaka A, Zeng QQ, Barnes J, Seyedin S, Martin G, Wechter WJ, Liang CT. Effect of minocycline on osteoporosis. Adv Dent Res. 1998;12:71-5.
14. Benitz KF, Roberts GK, Yusa A. Morphologic effects of minocycline in laboratory animals. Toxicol Appl Pharmacol. 1967;11:150-70.